eletriptan has been researched along with Arteriosclerosis, Coronary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davenport, A; Edvinsson, L; Longmore, J; Malmsjö, M; Uddman, E; Wackenfors, A | 1 |
| Buller, N; Cumberland, D; Hettiarachchi, J; Hillis, WS; Kirby, S; Newman, CM; Seabra-Gomes, R; Starkey, I | 1 |
1 trial(s) available for eletriptan and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Effects of sumatriptan and eletriptan on diseased epicardial coronary arteries.
Topics: Adult; Aged; Angiography; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Vessels; Double-Blind Method; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrrolidines; Sumatriptan; Tryptamines; Vasoconstrictor Agents; Vasodilation | 2005 |
1 other study(ies) available for eletriptan and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect.
Topics: Adult; Cerebral Arteries; Coronary Artery Disease; Coronary Vessels; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Male; Middle Aged; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstriction; Vasoconstrictor Agents; Vasomotor System | 2005 |